Skip to main content
Journal cover image

Tocilizumab in Refractory Autoimmune Encephalitis: A Series of Pediatric Cases.

Publication ,  Journal Article
Randell, RL; Adams, AV; Van Mater, H
Published in: Pediatr Neurol
September 2018

BACKGROUND: Autoimmune encephalitis can result in significant neurological and psychiatric morbidity and mortality in patients of all ages and often does not respond to standard therapies. Recent reports suggest efficacy of tocilizumab, a monoclonal antibody against interleukin 6, in refractory autoimmune encephalitis. RESULTS: We describe three children with refractory autoimmune encephalitis who experienced a robust, immediate clinical response following treatment with tocilizumab. CONCLUSION: These findings support the efficacy and short-term safety of tocilizumab as a third-line treatment for refractory autoimmune encephalitis in children.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Pediatr Neurol

DOI

EISSN

1873-5150

Publication Date

September 2018

Volume

86

Start / End Page

66 / 68

Location

United States

Related Subject Headings

  • Neurology & Neurosurgery
  • Male
  • Immunologic Factors
  • Humans
  • Hashimoto Disease
  • Female
  • Encephalitis
  • Drug Resistance
  • Child
  • Antibodies, Monoclonal, Humanized
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Randell, R. L., Adams, A. V., & Van Mater, H. (2018). Tocilizumab in Refractory Autoimmune Encephalitis: A Series of Pediatric Cases. Pediatr Neurol, 86, 66–68. https://doi.org/10.1016/j.pediatrneurol.2018.07.016
Randell, Rachel L., Ashley V. Adams, and Heather Van Mater. “Tocilizumab in Refractory Autoimmune Encephalitis: A Series of Pediatric Cases.Pediatr Neurol 86 (September 2018): 66–68. https://doi.org/10.1016/j.pediatrneurol.2018.07.016.
Randell RL, Adams AV, Van Mater H. Tocilizumab in Refractory Autoimmune Encephalitis: A Series of Pediatric Cases. Pediatr Neurol. 2018 Sep;86:66–8.
Randell, Rachel L., et al. “Tocilizumab in Refractory Autoimmune Encephalitis: A Series of Pediatric Cases.Pediatr Neurol, vol. 86, Sept. 2018, pp. 66–68. Pubmed, doi:10.1016/j.pediatrneurol.2018.07.016.
Randell RL, Adams AV, Van Mater H. Tocilizumab in Refractory Autoimmune Encephalitis: A Series of Pediatric Cases. Pediatr Neurol. 2018 Sep;86:66–68.
Journal cover image

Published In

Pediatr Neurol

DOI

EISSN

1873-5150

Publication Date

September 2018

Volume

86

Start / End Page

66 / 68

Location

United States

Related Subject Headings

  • Neurology & Neurosurgery
  • Male
  • Immunologic Factors
  • Humans
  • Hashimoto Disease
  • Female
  • Encephalitis
  • Drug Resistance
  • Child
  • Antibodies, Monoclonal, Humanized